We found 212 records for "Financial"

Articles

20 People who shaped healthcare in 2014 (Part 4)

2nd January 2015

 20 People who shaped healthcare in 2014 (Part 4)Articles

In the final instalment of our review of 2014, Andrew McConaghie looks at how patient advocates in rare diseases and 'activist investors' have shaped healthcare – and will continue to...

Read more

20 people who shaped healthcare in 2014 (part 2)

29th December 2014

 20 people who shaped healthcare in 2014 (part 2)Articles

In the second part of our review of 2014, Andrew McConaghie looks at five more individuals who played a prominent role in shaping healthcare this year - and all of...

Read more

AstraZeneca: reinvigorating a UK pharma giant

19th December 2014

 AstraZeneca: reinvigorating a UK pharma giantArticles

Lisa Anson, President of AstraZeneca UK & Ireland, talks to pharmaphorum about living through Pfizer's takeover bid and the company's expanding presence in diabetes and respiratory disease.As 2014 draws to...

Read more

Where pharma’s future lies

9th December 2014

 Where pharma’s future liesArticles

As payers increasingly look at costing the value a drug brings, pharma must focus on, and publicise, the wider benefits its treatments bring to society, and stop the 'sales' mentality...

Read more

News

JP Morgan: 2015 set to be a big year for advanced therapies

15th January 2015

 JP Morgan: 2015 set to be a big year for advanced therapiesNews

2014 was a watershed year for companies developing gene therapy and genome editing technologies, but 2015 is shaping up to be even better, according to speakers at this week's JP...

Read more

Pharma and biotech showcase at JP Morgan health conference

12th January 2015

 Pharma and biotech showcase at JP Morgan health conferenceNews

Opening today is the JP Morgan annual healthcare conference, a key date in the diary for leaders of pharma and biotech companies, who are all vying to dazzle investors with...

Read more

Shire adds rare disease drugs with $5.2bn NPS merger

12th January 2015

 Shire adds rare disease drugs with $5.2bn NPS mergerNews

Shire has agreed a deal to acquire US drugmaker NPS Pharma for $5.2bn and claim three drugs used to treat rare diseases.The $46-per-share deal - due to complete in February...

Read more

Antibiotics back in vogue as Merck cuts $9.5 billion deal for Cubist

9th December 2014

 Antibiotics back in vogue as Merck cuts $9.5 billion deal for CubistNews

Merck & Co has offered a hefty $9.5 billion to take control of US biotech Cubist Pharmaceuticals, in another signal that big pharma's interest in antibiotics research is returning.   Merck is...

Read more

White Papers

"The future ain’t what it used to be"

25th November 2014

 "The future ain’t what it used to be"White Papers

Preparation is key to creating and maintaining a strong drugs pipeline. However, the statistics demonstrate that successful product commercialisation strategies are not always implemented. Products are developed for which there...

Read more

Healthcare Innovation: the big ideas shaping the future of pharma

17th November 2014

 Healthcare Innovation: the big ideas shaping the future of pharmaWhite Papers

The transformation taking place in healthcare is challenging for everyone and adaptability is key for the pharma industry's continued success.Long production cycles, concentration on specialist drugs with high price tags,...

Read more

Redefining Market Access - Effective Value Engagement

3rd December 2013

 Redefining Market Access - Effective Value EngagementWhite Papers

Phenestra's latest white paper highlights the challenges in market access and reimbursement for every company involved in developing new and innovative drugs.Today, every pharmaceutical company has the patient at the...

Read more

Audio & Video

Live webinar/debate - Feb 4th - COPD, connecting real world needs to patient centric solutions

    COPD is a widespread, costly and largely preventable condition which affects over 300 million people worldwide and is recognised as the ‘third-leading’ cause of death in most countries. Adherence rates...

Read more

On demand webinar: The Price is Right? - Delivering UK access for niche patient populations

  With challenges to highly priced rare disease medicines and the Cancer Drug Fund evolving again – what is next, what are the ramifications for high priced/innovative treatments delivering beneficial outcomes...

Read more

Events

Moving towards integrated commissioning: how can we prepare for the future?

4th February 2015

Moving towards integrated commissioning: how can we prepare for the future?

Aimed at those responsible for commissioning health and social care within CCGs, local authorities and health and wellbeing boards, this conference will examine how to move towards a position whereby...

Read more

9th Clinical Trial Billing & Research Compliance Conference

8th February 2015

9th Clinical Trial Billing & Research Compliance Conference

With Sponsors, CROs, Sites, Physician Practices and Academic Medical Centers at the table discussing the revenue cycle and the impact of clinical trial billing, how can you go wrong? Together...

Read more

Ageing and Health: Policymaking in an era of longevity

9th February 2015

Ageing and Health: Policymaking in an era of longevity

How can societies meet the health, care and economic challenges of global ageing? One in nine people in the world is 60 or older and this is expected to rise to...

Read more

Africa Pharmaceutical Summit

11th February 2015 - 12th February 2015

Africa Pharmaceutical Summit

Returning for the 2nd year, AFRICA PHARMACEUTICAL SUMMIT (APS), held concurrently with the PHARMATECH AFRICA Exhibition, will place emphasis on interaction between participants to facilitate an open venue for debate...

Read more

Press Releases

New Schoonveld book is now available!

10th December 2014

New Schoonveld book is now available!

It's here!   The eagerly awaited new editon of THE PRICE OF GLOBAL HEALTH  is now available.   Written by global drug pricing expert Ed Schoonveld, The Price of Global Health (second edition) is...

Read more

Gower's latest Pharmaceutical and Healthcare Industry Catalogue

18th September 2014

Gower's latest Pharmaceutical and Healthcare Industry Catalogue

The latest Gower Pharmaceutical and Healthcare Industry Books Catalogue is now available online! Expanding on the Pharma and Health content this year, we have added details of books from our Governance & Leadership...

Read more

Aqurance launches Market Research & Predictive Analytics Services

3rd July 2014

Aqurance launches Market Research & Predictive Analytics Services

Athens, GR, July 02, 2014: Aqurance, a dynamic startup that specializes inLife Sciences consulting and technology implementation services, has recently announced the launch of a new business department, the Market...

Read more